false 0001574235 0001574235 2024-12-18 2024-12-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 18, 2024

 

 

PULMATRIX, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware   001-36199   46-1821392

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

945 Concord Street, Suite 1217

Framingham, MA 01701

(Address of principal executive offices) (Zip Code)

 

(888) 355-4440

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
Common Stock, par value $0.0001 per share   PULM   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On December 18, 2024, Pulmatrix, Inc. (the “Company”) held its 2024 annual meeting of stockholders (the “Annual Meeting”). A total of 1,856,171 shares of the Company’s common stock were present in person or represented by proxy at the Annual Meeting, which represented 50.82% of the outstanding shares of common stock entitled to vote at the Annual Meeting and constituted a quorum for the transaction of business. Holders of the Company’s common stock were entitled to one vote per share of common stock held as of the close of business on October 31, 2024, the record date for the Annual Meeting. The matters submitted for a vote and the related results are set forth below.

 

  (1) Election of two directors to serve as Class I directors on the Company’s Board of Directors to serve until the Company’s 2027 annual meeting of stockholders or until successors have been duly elected and qualified:

 

Director   For   Against   Withheld /Abstained   Broker Non-Votes
Todd Bazemore   285,646   0  

251,800

   1,318,725
Christopher Cabell, M.D.   334,230   0   203,216  

1,318,725

 

  (2) Ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the 2024 fiscal year:

 

For   Against   Withheld /Abstained   Broker Non-Votes
1,705,315   47,547   103,282  

0

 

For more information about the foregoing proposals, see the Company’s definitive proxy statement (the “Proxy Statement”) for the Annual Meeting, filed with the Securities and Exchange Commission on November 8, 2024, the relevant portions of which are incorporated herein by reference.

 

The results reported above are final voting results. No other matters were considered or voted upon at the meeting.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PULMATRIX, INC.
     
Date: December 20, 2024 By: /s/ Peter Ludlum
    Peter Ludlum
    Interim Chief Executive Officer

 

 

 

v3.24.4
Cover
Dec. 18, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 18, 2024
Entity File Number 001-36199
Entity Registrant Name PULMATRIX, INC.
Entity Central Index Key 0001574235
Entity Tax Identification Number 46-1821392
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 945 Concord Street
Entity Address, Address Line Two Suite 1217
Entity Address, City or Town Framingham
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01701
City Area Code (888)
Local Phone Number 355-4440
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol PULM
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Pulmatrix (NASDAQ:PULM)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Pulmatrix.
Pulmatrix (NASDAQ:PULM)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Pulmatrix.